Small cell neuroendocrine carcinoma of the breast: A report of three cases and review of the literature

Journal of Clinical Pathology

Volumn 58, Issue 7, 2005, Pages 775-778

  Adegbola, T ^a   Connolly, C E ^a   Mortimer, G ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN; CISPLATIN; CYTOKERATIN 20; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ETOPOSIDE; NEURON SPECIFIC ENOLASE; PROGESTERONE RECEPTOR; SYNAPTOPHYSIN; TUMOR MARKER;

ADULT; BREAST CARCINOMA; BREAST SMALL CELL NEUROENDOCRINE CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; NEUROENDOCRINE TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TISSUE STRUCTURE;

BREAST NEOPLASMS; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 21844472297     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.020792     Document Type: Review

References (15)

1. Samli B, Celik S, Evrensel T, et al. Primary neuroendocrine small cell carcinoma of the breast. Arch Pathol Lab Med 2000;124:296-8.
2. Ibrahim NB, Briggs JC, Corbishley CM. Extrapulmonary oat cell carcinoma. Cancer 1984;54:1645-61.
3. Richardson RL, Weiland LH. Undifferentiated small cell carcinomas in extrapulmonary sites. Semin Oncol 1982;9:484-96.
4. Shin SJ, DeLellis RA, Ying L, et al. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol 2000;24:1231-8.
5. Yamasaki T, Shimazaki H, Aida S, et al. Primary small cell (oat cell) carcinoma of the breast: report of a case and review of the literature. Pathol Int 2000;50:914-18.
6. Sapino A, Righi L, Cassoni P, et al. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 2000;17:127-37.
7. Salmo EN, Connolly CE. Primary small cell carcinomas of the breast: report of a case and review of the literature. Histopathology 2001;38:277-8.
8. Jundt G, Schulz A, Heitz PU, et al. Small cell neuroendocrine (oat cell) carcinoma of the male breast. Immunocytochemical and ultrastructural investigations. Virchows Arch A Pathol Anat Histopathol 1984;404:213-21.
9. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-78.
10. Hasleton PS. New WHO classification of lung tumours. Recent Advances in Histopathology 2001;19:115-29.
11. Miremadi A, Pinder SE, Lee AH, et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 2002;40:215-22.
12. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40:403-39.
13. Chan JK, Suster S, Wenig BM, et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226-34.
14. Guinee DG Jr, Fishback NF, Koss MN, et al. The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. Am J Clin Pathol 1994;102:406-14.
15. Suster S, Moran CA. Neuroendocrine carcinoma. In: Modern surgical pathology, Vol. 1. USA: Elsevier Science, 350-5.